Back to News
Market Impact: 0.34

RBC Capital raises Starbucks stock price target on sales momentum By Investing.com

SBUXWFCEVRUBS
Corporate EarningsCorporate Guidance & OutlookAnalyst EstimatesAnalyst InsightsCompany FundamentalsConsumer Demand & Retail
RBC Capital raises Starbucks stock price target on sales momentum By Investing.com

Starbucks beat consensus on both revenue and earnings, with North America same-store sales growth of 7.1% versus 4.2% expected, and management raised full-year FY26 same-store sales and EPS guidance. Offsetting the beat, North American margins missed estimates and the guidance implies second-half Street EPS estimates will come down. RBC Capital lifted its price target to $110 from $105 while keeping a Sector Perform rating; several other brokers also raised targets to $95-$115.

Analysis

The market is rewarding the visible part of the turnaround — traffic and top-line momentum — but the cleaner read is that this is now a margin-and-duration story, not a one-quarter beat story. When a consumer brand with an already rich multiple is forced to guide near-term EPS off the Street’s path while still talking up growth, the multiple usually holds only if investors believe the comps are durable for at least 2-3 more quarters. The current setup says the easy re-rating from “fix the business” to “show me the money” is largely done. The second-order effect is on rivals and inputs: if Starbucks is sustaining higher checks without immediate margin repair, competitors in premium coffee and beverage chains will try to copy price/mix rather than volume, which risks a sector-wide affordability squeeze into 2026. At the same time, margin pressure in North America likely means labor and occupancy leverage are still not fully under control, so any slip in traffic would hit earnings disproportionately. That makes the next few months more important than the year-ahead guide — the stock can work on continued estimate resets lower, but it becomes fragile if same-store sales decelerate even modestly. Consensus appears to be underpricing the valuation risk more than the operating improvement. A premium multiple can survive a transient miss; it does not survive repeated evidence that margin recovery is slower than sales recovery. The market is implicitly assuming this is a multi-year compounding story, but the guidance dynamic suggests fiscal 2H estimate compression is still ahead, which is usually when high-multiple consumer names lose momentum even if the headline quarter was fine.